It is important that people living with mental health disorders know that there is no one-size-fits-all approach.
What are schizophrenia and bipolar I disorder?
Having multiple treatment options is important because not every patient is the same.
LAIs providecontinuousdelivery of antipsychotic medication and help maintain appropriate blood levels of that medication.
These injectables offer an additional treatment option to maintain stability for patients living with bipolar I disorder.
Ensure with your doctor that you’re free to tolerate aripiprazole prior to starting treatment.
It starts with speaking to a health care professional to determine if an LAI is the right fit.
The efficacy and safety of ABILIFY ASIMTUFII is based on the pivotal studies of ABILIFY MAINTENA (aripiprazole).
ABILIFY MAINTENA is the first and only FDA-approved once-monthly maintenance treatment for bipolar I in adults.
Some patients with bipolar I disorder and their caregivers may consider trying ABILIFY MAINTENA as a potential treatment option.
This treatment is administered by a health care professional via intramuscular injection once a month.
To learn more, visithttps://www.abilifyasimtufii.com/.
IMPORTANT SAFETY INFORMATION:
Increased risk of death in elderly people with dementia-related psychosis.
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis.
Uncontrolled body movements (tardive dyskinesia).
Tardive dyskinesia may not go away, even if you stop receiving ABILIFY ASIMTUFII or ABILIFY MAINTENA.
Tardive dyskinesia may also start after you stop receiving ABILIFY ASIMTUFII or ABILIFY MAINTENA.
Extremely high blood sugar can lead to coma or death.
Weight gain.You and your health care provider should check your weight regularly during treatment.
IMPORTANT SAFETY INFORMATION (cont’d)
Unusual and uncontrollable (compulsive) urges.
Other compulsive urges include sexual urges, shopping, and eating or binge eating.
Low white blood cell count.Your health care provider may do blood tests during the first few months of treatment.
Problems controlling your body temperature so that you feel too warm.
Do notbecome too hot or dehydrated during treatment with ABILIFY ASIMTUFII or ABILIFY MAINTENA.Do notexercise too much.
In hot weather, stay inside in a cool place if possible.
Stay out of the sun.Do notwear too much clothing or heavy clothing.
Drink plenty of water.
Difficulty swallowingthat can cause food or liquid to get into your lungs.
Do notdrink alcohol during treatment with ABILIFY ASIMTUFII or ABILIFY MAINTENA.
ABILIFY ASIMTUFII or ABILIFY MAINTENA may harm your unborn baby.
you’ve got the option to register by calling 1-866-961-2388 or visithttps://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/.
are breastfeeding or plan to breastfeed.
ABILIFY ASIMTUFII or ABILIFY MAINTENA can pass into your milk and may harm your baby.
ABILIFY ASIMTUFII or ABILIFY MAINTENA and other medicines may affect each other causing possible serious side effects.
These are not all the possible side effects of ABILIFY ASIMTUFII or ABILIFY MAINTENA.
If you have any questions about your health or medicines, talk to your health care provider.
You are encouraged to report side effects of ABILIFY ASIMTUFII and ABILIFY MAINTENA.
like contact Otsuka America Pharmaceutical Inc. at 1-800-438-9927 or the FDA at 1-800-FDA-1088 (www.fda.gov/medwatch1).
c’mon see FULL PRESCRIBING INFORMATION, includingBOXED WARNING, and MEDICATION GUIDE forABILIFY ASIMTUFIIandABILIFY MAINTENA.
